94111 ⎘
Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring; Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
NOVEL MICROBIAL GENOTOXINS
#2COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#3METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES
#4METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES
#5A CONTINUOUS FLOW PROCESS FOR SYNTHESIS OF ORGANIC AZIDES
#6COMPOUNDS AND METHODS FOR INHIBITING FASCIN
#7COMPOUND FOR TREATING THROMBOTIC DISEASES
#8COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#9COMPOSITIONS AND METHODS FOR SUPPRESSING AND/OR TREATING METABOLIC DISEASES AND/OR A CLINICAL CONDITION THEREOF
#10OPTICAL ABSORBENT COMPOSITION
#11SULFONAMIDE SUBSTITUTED N-(1H-INDOL-7-YL)BENZENESULFONAMIDES AND USES THEREOF
#12Compounds and methods for inhibiting fascin
#13Method of preparing indolin-2-one compound and method of using indolin-2-one
#14COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#15COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#16COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#17COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#18BENZOPYRAZOLE COMPOUNDS AND ANALOGUES THEREOF
#19Indoles, Indazoles, and Related Analogs for Inhibiting YAP/TAZ-TEAD
#20INDIRUBIN DERIVATIVES, AND USES THEREOF
#21COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#22COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#23MATERIAL FOR FORMING ORGANIC FILM, PATTERNING PROCESS, AND COMPOUND
#24COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#25COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#26INHIBITORS OF APOL1 AND METHODS OF USING SAME
#27COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#28Conducting reactions in Leidenfrost-levitated droplets
#29COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#30ISOINDOLINE DERIVATIVES
#315-BROMO-INDIRUBINS
#32SUBSTITUTED FUSED BI- OR TRI- HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS
#33Compounds and compositions for treating conditions associated with STING activity
#34METHODS USING HDAC11 INHIBITORS
#35COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#36COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#37COMPOSITIONS AND METHODS FOR SUPPRESSING AND/OR TREATING METABOLIC DISEASES AND/OR A CLINICAL CONDITION THEREOF
#38Compounds and methods for inhibiting fascin
#39Indole compounds and analogues thereof
#40Selective inhibitors of 12(S)-lipoxygenase (12-LOX) and methods for use of the same
#41Conducting reactions in leidenfrost-levitated droplets
#425-Bromo-indirubins
#43Indole (sulfomyl) n-hydroxy benzamide derivatives as selective HDAC inhibitors
#445-bromo-indirubins
#45Indirubin derivatives, and uses thereof
#46Methods using HDAC11 inhibitors
#47Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
#48Compounds and methods for inhibiting fascin
#49SUBSTITUTED FUSED BI- OR TRI- HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS
#50Indoline analogs and uses thereof
#51ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS
#52Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
#53Amino compounds for treatment of complement mediated disorders
#54Benzopyrazole compounds and analogues thereof
#55Phosphonate compounds for treatment of complement mediated disorders
#56Methods using HDAC11 inhibitors
#57Methods using HDAC11 inhibitors
#58Compounds and methods of treating infections
#59Ether compounds for treatment of complement mediated disorders
#60Compounds for treatment of complement mediated disorders
#61Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
#62Therapeutic compounds
#63Alkyne Compounds for Treatment of Complement Mediated Disorders
#64ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS
#65ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS
#66Compounds and methods for inhibiting fascin
#675-BROMO-INDIRUBINS
#685-bromo-indirubins
#69Antibiotic sensitivity-restoring and photosensitive agents
#703-amino-1,5,6,7-tetrahydro-4H-indol-4-ones
#71METHODS USING HDAC11 INHIBITORS
#72Cyclic vinylogous amides as bromodomain inhibitors
#73ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS
#74Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
#75Compounds for treatment of complement mediated disorders
#76Ether compounds for treatment of complement mediated disorders
#77Polymerizable compound and optically anisotropic object
#78Indoline analogs and uses thereof
#79Conducting reactions in Leidenfrost-levitated droplets
#80Carbamate, ester, and ketone compounds for treatment of complement mediated disorders
#81Amide compounds for treatment of complement mediated disorders
#82Indoline analogs and uses thereof
#83Polymerizable compound, composition, polymer, optically anisotropic body, liquid crystal display element, and organic EL display
#84BENZOTHIOPHENE, BENZYLOXYBENZYLIDENE AND INDOLINE DERIVATIVES USEFUL FOR THE TREATMENT OF TUBERCULOSIS
#85Factor D Inhibitors Useful for Treating Inflammatory Disorders
#86Amino compounds for treatment of complement mediated disorders
#87Isoxazole treatments for frontotemporal dementia
#88Compounds and methods for inhibiting fascin
#89Guanidine compounds and use thereof
#90Pharmaceutical compound
#91Amide compounds for treatment of complement mediated disorders
#92COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS
#93Antibacterial agents: Nα-aroyl-N-aryl-phenylalaninamides
#94Benzamides and nicotinamides as Syk modulators
#95Antibiotic sensitivity-restoring and photosensitive agents
#96Cyclic vinylogous amides as bromodomain inhibitors
#97Compounds and methods of treating infections
#985-BROMO-INDIRUBINS
#99SMYD2 inhibitors
#100Oxindole compounds carrying a CO-bound spiro substituent and use thereof for treating vasopressin-related diseases
#101Hydrazone modulators of cannabinoid receptors
#102Compounds and methods for inhibiting fascin
#103Inhibitors of histone methyltransferase G9a
#104Organic electroluminescent device
#1055-BROMO-INDIRUBINS
#106Phosphonate compounds for treatment of complement mediated disorders
#107Ether compounds for treatment of complement mediated disorders
#108Carbamate, ester, and ketone compounds for treatment of complement mediated disorders
#109Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
#110Amino compounds for treatment of complement mediated disorders
#111Amide compounds for treatment of complement mediated disorders
#112Alkyne compounds for treatment of complement mediated disorders
#113Compounds for treatment of complement mediated disorders
#114Factor D inhibitors useful for treating inflammatory disorders
#115Kinase protein binding inhibitors
#116Method of using an indolinone molecule and derivatives for inhibiting liver fibrosis and hepatitis
#117Benzamides and nicotinamides as Syk modulators
#118Indolyl or indolinyl hydroxamate compounds
#119Arylosulfonamides for the treatment of CNS diseases
#120Indirubin derivatives, and uses thereof
#121Quinoxaline compounds and derivatives
#122Indirubin derivatives and uses thereof in treating chronic myelogenous leukemia
#123Hydrazone modulators of cannabinoid receptors
#124Antiviral drugs for treatment of arenavirus infection
#125NOVEL METHODS FOR THE PREPARATION OF P2X7R ANTAGONISTS
#126Benzylidene-indolinone compounds and their medical use
#127Fungicidal Iminoderivatives
#128Biologically active compound N-[3-(4-nitrophenylamino)-indole-2-ilmethylene]aminoguanidine hydrochloride with anti-inflammatory activity
#129N,N′-hydrazino-bis-isatin derivatives with selective activity against multidrug-resistant cancer cells
#130Quinoxaline compounds and derivatives
#1312-aminoindole compounds and methods for the treatment of malaria
#132Substituted indole and azaindole oxoacetyl piperazinamide derivatives
#133Antiviral drugs for treatment of arenavirus infection
#134INDOLEAMINE 2,3-DIOXYGENASE PATHWAYS IN THE GENERATION OF REGULATORY T CELLS
#135Benzamides and nicotinamides as Syk modulators
#136Substituted Oxindole Derivatives, Medicaments Containing Said Derivatives and Use Thereof
#137Carboxy isatin hydrazones and their esters as Shp2 inhibitors
#138Indolyl or indolinyl hydroxamate compounds
#139Benzenesulfonamide derivatives and pharmaceutical composition thereof
#140P2X7R antagonists and their use
#141Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
#1423′,6-substituted indirubins and their biological applications
#143Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof
#144Substituted Nitrogen Heterocycles and Synthesis and Uses Thereof
#145Pharmaceutical process and intermediates 714
#146NOVEL ANDROGENS
#1477-substituted indirubin-3′oximes and their applications
#148Triazinone and diazinone derivatives useful as HSP90 inhibitors
#149P2X7R antagonists and their use
#150Sulfonamides and their use as a medicament
#151SUBSTITUTED 3-(4-HYDROXYPHENYL)-INDOLIN-2-ONE COMPOUNDS
#152INDOL-2-ONE DERIVATIVES DISUBSTITUTED IN THE 3-POSITION, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
#153Hydrazone modulators of cannabinoid receptors
#154B1-antagonists
#1552-ARYL OR HETEROARYL INDOLE DERIVATIVES
#156Non-Nucleoside Reverse Transcriptase Inhibitors
#157OXINDOLE HYDRAZIDE MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPS)
#158Organic electroluminescent device
#159SYNTHESIS OF THROMBOPOIETIN ACTIVITY MODULATING COMPOUNDS
#160Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
#161Substituted Nitrogen Heterocycles and Synthesis and Uses Thereof
#162Aminoindane derivative or salt thereof
#1632-indolinone derivatives as selective histone deacetylase inhibitors
#164Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
#165INDOLEAMINE 2,3-DIOXYGENASE PATHWAYS IN THE GENERATION OF REGULATORY T CELLS
#166Phenylpiperazine
#167SUBSTITUTED BENZYL AMINE COMPOUNDS
#1683-amino-1-arylpropyl indoles and AZA-substituted indoles and uses thereof
#169Inhibitors of cysteine proteases and methods of use thereof
#170COMPOUNDS AND METHODS OF USE
#171Antiviral drugs for treatment of arenavirus infection
#1721,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle
#173CB1 modulator compounds
#174Substituted AZA-indoles as inhibitors of poly(ADP-ribose) polymerase (PARP)
#175Benzamidine derivatives having anti-inflammatory and immunosuppressive activity
#176Inhibition of Shp2/PTPN11 protein tyrosine phosphatase by NSC-87877, NSC-117199 and their analogs
#177Thrombopoietin activity modulating compounds and methods
#178Heteroarylphenylurea derivative
#179THROMBOPOIETIN ACTIVITY MODULATING COMPOUNDS AND METHODS
#180Substituted benzyl amine compounds
#181Inhibitors of c-JUN N-terminal kinases (JNK)
#182Compositions and methods for modulating gated ion channels
#183Compositions and methods for modulating gated ion channels
#184Novel biaromatic compounds that modulate PPAR type receptors and cosmetic/pharmaceutical compositions comprised thereof
#185Compositions and methods for modulating gated ion channels
#186INHIBITORS OF SOLUBLE ADENYLATE CYCLASE
#187Use of GAL3 antagonist for treatment of depression and/or anxiety and compounds useful in such methods
#188Indole compounds having sphingosine-1-phosphate (S1P) receptor antagonist
#189Hedgehog pathway antagonists
#190Androgens
#191Indirubin derivatives having anticancer property against human cancer cell line
#192Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity
#1933-amino-1-arylpropyl indoles and aza-substituted indoles and uses thereof
#194Oxindole compounds and their uses as therapeutic agents
#195CB1 antagonist compounds
#1961-sulfonylindole derivatives, their preparation and their use as 5-HTligands
#197Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
#198Phenylpiperazines
#199Aminoalkylphenyl indolone derivatives
#200Aminoalkoxyphenyl indolone derivatives
#201Diarylurea derivatives and their use as chloride channel blockers
#202Thrombopoietin activity modulating compounds and methods
#203PPAR active compounds
#204Aryl ureido benzoic acid derivatives and their use
#205Process for the preparation of α-aminosubstituted carboxylic acid amides
#206Indolinone hydrazides as c-Met inhibitors
#207Substituted oxindole derivatives as tyrosine kinase inhibitors
#208Processes and polymorphs of diaryl-indolone galr3 antagonists
#209Thio-oxindole derivatives
#2103-imino-2-indolones for the treatment of depression and/or anxiety
#211(Oxime)carbamoyl fatty acid amide hydrolase inhibitors
#212Benzylcycloalkyl amines as modulators of chemokine receptor activity
#213Compounds and methods of use
#214Thio-oxindole derivatives
#215Substituted indoles as inhibitors of poly (ADP-ribose) polymerase (PARP)
#216Oxindole hydrazide modulators of protein tyrosine phosphatases (PTPs)
#217Indole-based chalcone compounds as antibacterial agents